| abstract |
An injectable, dermal filler composition comprises polyethylene oxide diacrylate (PEODA), hyaluronic acid, triethanolamine and an accelerant. The accelerant may be N-vinyl pyrrolidone, 2-vinyl pyridine, 1-vinyl imidazole, 9-vinyl carbazole, acrylic acid or 2-allyl, 2-methyl, 1-3-cyclopentanedione. Preferably, the accelerant is N-vinyl pyrrolidone. In another aspect an injectable, dermal filler composition comprises polyethylene oxide diacrylate (PEODA), modified hyaluronic acid and triethanolamine, wherein the ratio between the PEODA and modified hyaluronic acid is greater than 1:1 w/w. Optionally, the composition may comprise an accelerant, which may be N-vinyl pyrrolidone. The composition may further comprise eosin Y. |